The QualityStocks Daily Monday, May 7th, 2018

Today's Top 3 Investment Newsletters

Trader Power News (BLNK) +172.97%

Penny Picks (DAVC) +67.33%

Penny Stock Titans (STHC) +30.00%

The QualityStocks Daily Stock List

MGT Capital Investments, Inc. (MGTI)

OTC Markets and InvestorsHub reported on MGT Capital Investments, Inc. (MGTI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

MGT Capital Investments, Inc. ranks as one of the largest U.S.-based Bitcoin miners. The Company has its facility in Washington State. It also has a facility in northern Sweden. Additionally, MGT continues to concentrate on an expansion model to grow its crypto assets materially. MGT Capital Investments is headquartered in Durham, North Carolina. The Company lists on the OTC Markets Group’s OTCQB.

The Company signed a Letter of Intent (LOI) with Bitmain Technologies Limited. This is to establish a JV that will center on opportunities in the Bitcoin space in North America. The proposed JV between MGT Capital Investments and Bitmain Technologies will lead to the development of a state-of-the-art Bitcoin mining pool.

Moreover, MGT Capital Investments entered into a consulting agreement with Future Tense Secure Systems, Inc. Future Tense is a technology incubator with investments in other applications requiring privacy, such as file sharing and chat.

This past January, MGT Capital Investments announced the end of its business relationship with cybersecurity pioneer Mr. John McAfee. Since August of 2017, Mr. McAfee had served as Chief Cybersecurity Visionary of MGT, guiding the development of its cybersecurity business, including Sentinel and the privacy phone.

Moreover, in March, MGT announced that it ended its cybersecurity operations by selling the Sentinel product line to a new entity created by the unit's management team, and ending development of the privacy phone. The Sentinel assets sold for $60,000 in cash and a $1.0 million promissory note, convertible into a 20 percent equity interest of the buyer.

Company Management referred to the high level of investment and cash burn associated with cybersecurity for its decision to exit Sentinel. MGT Capital Investments commenced Bitcoin Mining in September of 2016 in Washington State.

These facilities are still currently mining. In Q1 2018, MGT started a transition of its mining assets from Washington State to Northern Sweden. The Company owns and operates Bitmain Antminer S9 Bitcoin mining rigs and graphics processing unit-based Ethereum miners.

MGT Capital Investments, Inc. (MGTI), closed Monday's trading session at $1.63, down 4.12%, on 442,440 volume with 463 trades. The average volume for the last 60 days is 732,517 and the stock's 52-week low/high is $0.46/$8.14.

GT Biopharma, Inc. (GTBP)

Stockopedia, Insider Financial, InvestorsHub, Stockhouse, and OTC Markets reported on GT Biopharma, Inc. (GTBP), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

GT Biopharma, Inc. focuses on innovative drugs for the treatment of cancer and CNS diseases (Neurology and Pain), along with other unmet medical needs. The Company’s lead oncology drug candidate is OXS-1550 (DT2219ARL). It owns the worldwide rights to commercialize OXS-1550. Its present CNS pipeline products include treatment for neuropathic pain, the symptoms of myasthenia gravis, as well as motion sickness.

A biotechnology company, GT Biopharma is based in Tampa, Florida. GT Biopharma completed its merger with GTP (Georgetown Translational Pharmaceuticals, Inc.). This merger brought in new management and a class of close-to-market Central Nervous System (CNS) products to GT Biopharma.

The Company is targeting multiple myeloma, triple-negative breast cancer, non-Hodgkin’s lymphoma, and more. It is doing so with highly potent biopharmaceutical drugs designed for targeted therapy.

GT Biopharma’s OXS-1550 is an ADC (Antibody Drug Conjugate) drug. What makes OXS-1550 (DT2219ARL) different from other treatments, such as chemotherapy, is that the design of it is to specifically target and kill cancer cells while reducing damage to normal tissues.

OXS-1550 is a bispecific scFv recombinant fusion protein-drug conjugate. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia.

OXS-1550 targets cancer cells expressing the CD19 receptor or the CD22 receptor or both receptors. When OXS-1550 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of cytotoxic payload.

The Company’s OXS-3550 TriKE technology was developed by researchers at the University of Minnesota Masonic Cancer Center. This targeted immunotherapy directs immune cells to kill cancer cells while decreasing drug-related toxicity.

GT Biopharma’s CNS platform centers on acquiring or discovering and patenting late-stage, de-risked, and close-to-market improved treatments for CNS diseases. It also centers on guiding the products through the Food and Drug Administration (FDA) approval process to the NDA.

Earlier this month, GT Biopharma announced that it completed dosing in its Phase 1 clinical trial for GTP-004. This is the Company’s promising treatment for the symptoms of myasthenia gravis. Myasthenia gravis is a rare autoimmune muscle disease. It is caused by antibodies that attack certain components of muscles leading to varying degrees of weakness and fatigue.

The results provide evidence that GTP-004 enables the safe and well-tolerated administration of doses of pyridostigmine. The goal of the Phase 1 clinical trial is to demonstrate that GI side effects are safely reduced with GTP-004.

GTP-004 combines pyridostigmine with ondansetron, designed to soothe the gastro-intestinal (GI) side effects of pyridostigmine alone, providing the potential for a fully effective dose of pyridostigmine to be safely used. Based on the data, and discussions with key opinion leaders, GT Biopharma expects to be in a position to begin a Phase 2 clinical trial in patients in the second half of this year.

GT Biopharma, Inc. (GTBP), closed Monday's trading session at $1.41, up 12.80%, on 91,578 volume with 170 trades. The average volume for the last 60 days is 82,260 and the stock's 52-week low/high is $1.19/$36.90..

Leafbuyer Technologies, Inc. (LBUY)

Barchart, Insider Financial, and OTC Markets reported on Leafbuyer Technologies, Inc. (LBUY), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Leafbuyer Technologies, Inc. is a top cannabis technology platform. Leafbuyer is one of the most wide-ranging online sources for searchable cannabis deals, specials, and also menu’s. Leafbuyer is the official marijuana deals platform of Voice Media Group, Grasscity, Dope Media and LA Weekly. Formed in 2012, Leafbuyer Technologies has its headquarters in Greenwood Village, Colorado.

Leafbuyer’s online network reaches millions of marijuana consumers each month. Leafbuyer Technologies continues to expand into every legal state. The Company is working to be the ultimate cannabis resource, providing consumers and businesses with the resources they require to thrive in the cannabis industry.

Leafbuyer.com connects consumers with dispensaries. The Company works alongside businesses to highlight their unique products and build a network of loyal patrons.

Leafbuyer Technologies announced last year that it entered into expansion agreements with two major dispensary chains. These are Sweet Leaf Marijuana Centers and Green Dragon Cannabis Co.

Leafbuyer Technologies is strategically positioned for considerable expansion into the California Recreational cannabis market this year. With the passage of Proposition 64, effective January 1, 2018, California residents no longer need doctor’s approval to purchase cannabis. Leafbuyer says the Company is well-prepared to connect consumers with dispensaries across California.

This past March, Leafbuyer Technologies announced that Phase Two of its advanced large-scale platform based on blockchain technology has started. Working with its select specialists, Wunderkind Technologies, LLC, the second strategic phase has started to reliably verify transactions with dispensaries. Blockchain will allow Leafbuyer Technologies’ systems management team to accurately, in real time, verify referrals, customer traffic, point-of-purchase, pricing and a broad number of proprietary data points for Leafbuyer’s clients.

Moreover, last month, Leafbuyer Technologies announced its new partnership with DOPE Media. The new partnership will expand the reach of Leafbuyer's deals platform to millions of new cannabis users throughout North America. DOPE Media is a highly-respected media veteran in the legal cannabis industry.

Leafbuyer Technologies has launched Leafbuyer TV. This is the new television arm of the Company. Leafbuyer TV will include television news style segments to complement and enhance the Leafbuyer.com News and Blog section of its website, and also Leafbuyer’s social media platforms. This new TV service will be free to the public.

Leafbuyer Technologies, Inc. (LBUY), closed Monday's trading session at $1.47, up 0.60%, on 162,446 volume with 248 trades. The average volume for the last 60 days is 171,273 and the stock's 52-week low/high is $0.84/$3.82.

Sprott, Inc. (SPOXF)

Stock Gumshoe, StreetInsider, Stockhouse, InvestorsHub, Stockwatch, 4-Traders, The Street, and Tip Ranks reported on Sprott, Inc. (SPOXF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

A worldwide asset manager, Sprott, Inc. provides investors with access to highly-differentiated precious metals and real assets investment strategies. The Company’s best-in-class investment products include unique physical bullion trusts, mining ETFs (exchange-traded funds), as well as private equity and debt strategies.

Listed on the OTC Markets, Sprott has its headquarters in Toronto, Ontario. The Company also has offices in Connecticut, Carlsbad, California, and Vancouver, British Columbia.

Furthermore, Sprott partners with natural resource companies to meet their capital requirements through its merchant banking and resource lending activities.

Sprott was established in 1981 by Mr. Eric Sprott, an early champion of precious metals and real assets investing. Today, Sprott serves greater than 200,000 international clients. In addition, the Company has over C$11.5 billion in assets under management after the acquisition of Central Fund of Canada Limited.

Sprott’s unique capabilities permit it to provide flexible financing solutions across the mining life cycle. The Company’s capabilities also allow it to match worldwide investor demand with a strong pipeline of investment opportunities.

By way of its subsidiaries, Sprott provides asset management, portfolio management, wealth management, fund management, and administrative and consulting services to its clients. The firm offers mutual funds, hedge funds, and offshore funds, along with managed accounts. Additionally, Sprott provides broker-dealer activities.

Regarding Asset Management, Sprott offers Sprott Physical Bullion Trusts, Sprott ETFs, and Actively-Managed Strategies. Concerning Resource Financing, the Company has its Sprott Resource Lending, Sprott Capital Partners, and Sprott Resource Holdings.

Pertaining to Wealth Management, the Company provides wealth management services to U.S., Canadian, and global clients via its subsidiaries - Sprott US and Sprott Private Wealth.

In late March 2018, Mr. Eric Sprott announced that he holds and controls, indirectly (by way of his holding company, 2176423 Ontario Ltd. and The Sprott Foundation), 25,048,678 common shares (shares) of Sprott, Inc. This represents roughly 9.99 percent of the outstanding shares.

The press release was issued pursuant to Canadian early warning requirements because the sale of shares combined with Sprott, Inc.'s treasury issuances of shares, resulted in Mr. Sprott's beneficial holdings of shares to decrease to less than 10 percent of the outstanding shares.

Sprott, Inc. (SPOXF), closed Monday's trading session at $2.53, down 2.17%, on 263,671 volume with 310 trades. The average volume for the last 60 days is 388,114 and the stock's 52-week low/high is $1.44/$3.29.

Bionik Laboratories Corp. (BNKL)

Stockhouse, MarketWatch, and OTC Markets reported on Bionik Laboratories Corp. (BNKL), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Bionik Laboratories Corp. is a robotics company centered on providing rehabilitation and assistive technology solutions to individuals with neurological and mobility challenges from hospital to home. Via the acquisition of Interactive Motion Technologies, the Company has added a portfolio of products focused on upper and lower extremity rehabilitation of stroke patients and other mobility-impaired patients.

Bionik completely integrated Interactive Motion Technologies, Inc. into the Company following the May 2016 acquisition. Bionik Laboratories formed in 2010, and the Company has its corporate headquarters in Toronto, Ontario. Bionik has its U.S. headquarters in Watertown, Massachusetts.

The Company has three products available on the market and four products in different stages of development. The design of the InMotion Systems - the InMotion ARM™, InMotion WRIST™, InMotion HAND™ and InMotion ANKLE™, are to provide intelligent, patient-adaptive therapy in a way that has been clinically verified to maximize neuro-recovery.

The InMotion WRIST is an evidence based and research proven interactive rehabilitation device. InMotion WRIST senses patient movements and limitations. Additionally, it provides assistance-as-needed™. It can accommodate the range of motion of a normal wrist in daily tasks. InMotion WRIST can be used by clinicians as a stand-alone treatment option or in addition to the InMotion ARM.

The InMotion ARM is an evidence based intelligent, interactive rehabilitation technology. It senses patient movements and limitations, providing assistance-as-needed™ in real-time.

The InMotion HAND is an add-on module to be utilized with the InMotion ARM™. These two work together to provide assist-as-needed™ support for reaching with grasp and release movements, or independently for focused training on individual hand movements.

Furthermore, Bionik is developing a lower-body exoskeleton, ARKE™. The design of ARKE™ is to allow paraplegics and other wheelchair users the ability to rehabilitate through walking.

During Fiscal Year 2018 that ended March 31, 2018, Bionik Laboratories launched the next-generation InMotion™ Arm, and improved its supply chain with the outsourcing of manufacturing. Bionik launched its next-generation InMotion Arm interactive robotic system for the clinical rehabilitation of stroke survivors and those with mobility impairments due to neurological conditions. The improved new generation InMotion Arm will provide the same innovative active-assisted robotic therapy. The Company also expanded its worldwide reach with a distribution agreement with Curexo of South Korea and shipping its first systems to Curexo.

Bionik Laboratories Corp. (BNKL), closed Monday's trading session at $0.06, up 7.91%, on 23,600 volume with 7 trades. The average volume for the last 60 days is 69,622 and the stock's 52-week low/high is $0.055/$0.40.

Durango Resources, Inc. (ATOXF)

Penny Stock Hub, Stockhouse, OTC Markets, MarketWatch, Barchart, WalletInvestor, InvestorX, OTC Stock Watch, Resource World, Investors Guru, Stockwatch, High Rising Stocks, and Jet Life Penny Stocks reported on Durango Resources, Inc. (ATOXF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

A junior mining company, Durango Resources, Inc. acquires and explores for precious and base mineral properties in Canada. The Company previously went by the name Atocha Resources, Inc. It changed its name to Durango Resources, Inc. in February of 2013. Incorporated in 2006, Durango Resources is based in Vancouver, British Columbia.

Durango Resources’ common shares started trading on the OTCQB® Venture Market in the United States under the symbol “ATOXF” on March 13, 2018.

The Company has a large asset pool of claims. It has projects in strategic areas adjoining Osisko, Nemaska Lithium, Lakeshore Gold, GT Gold, and Garibaldi Resources. Durango Resources has 100 percent owned Canadian properties.

The Company’s properties include Dianna Lake, Saskatchewan; Whitney Northwest, Ontario; NMX East, Quebec; Decouverte (Discovery), Quebec; Mayner’s Fortune, British Columbia; Windfall Lake Properties, Quebec; and Buckshot Graphite, Quebec.

Durango Resources’ Decouverte Property in James Bay, Quebec had an independent technical review completed as reported on January 16, 2018. The review supports a drilling program of 3,800 meters across 36 holes.

Six target areas are defined on the property. Each of these ranges from 100 meters to 400 meters along strike. Because of the prior exploration evidence of a well-preserved gold system, Durango Resources expects to test drill these targets this summer.

Decouverte is a grassroots gold project. It is targeting greenstone-hosted orogenic gold mineralization. The Decouverte property is 57 square kilometers (5,700 ha).

Recently, Durango Resources reported the results from its reconnaissance visit to the claims bordering GT Gold in the Golden Triangle of British Columbia. Rock samples taken from the Grizzly area returned 26 ppb Gold (Au) in sample # 82277, 2.12 ppm (2.12 g/t) Silver (Ag) in sample # 82272, 0.015 percent Copper (Cu) in sample # 82262, and 0.010 percent Copper (Cu) in sample # 82270. The Cobalt (Co) highest grades were 33.4 ppm in sample # 82254 and 26.5 ppm in sample # 82251.

The project geologist recommended ground geophysics (including electromagnetic, induced polarization and gamma radiometric survey), more rock and soil sampling, as well as mapping of selected areas as follow up work required this year.

Last month, Durango Resources announced that it holds reconfigured claims situated in the southern part of the Windfall Lake area. This includes ground that is parallel to the south of BonTerra Resources where BonTerra announced discovery of a “new sixth parallel gold zone at the Gladiator gold deposit.”

Mrs. Marcy Kiesman, Durango Resources’ Chief Executive Officer, stated, “Durango is very excited with this new sixth parallel zone at the Gladiator gold deposit with the continued success of Bonterra’s Gladiator project at Windfall Lake. This confirmation of the continuity of the zones being parallel and situated in the southwest portion of the Gladiator property and bodes well for the potential of Durango’s ground south of BonTerra.”

Durango Resources, Inc. (ATOXF), closed Monday's trading session at $0.0662, even for the day. The average volume for the last 60 days is 5,703 and the stock's 52-week low/high is $0.045/$0.0826.

Liberated Syndication, Inc. (LSYN)

Promotion Stock Secrets reported on Liberated Syndication, Inc. (LSYN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Liberated Syndication, Inc. engages in the podcast hosting services business in the United States. The Company previously went by the name Webmayhem, Inc. It changed its name to Liberated Syndication, Inc. in August of 2016. The Company has its corporate office in Pittsburgh, Pennsylvania. Liberated Syndication’s shares trade on the OTC Markets’ OTCQB.

Regarding the Company’s OnPublish – Multiple Destination Publishing, Liberated Syndication’s services provide independent podcasters tools to create a first-rate podcast and get that podcast into as many platforms as possible. The Company is the largest leading podcast network. It provides podcast hosting services for producers of podcasting content; independent podcasters’ tools to publish content; and mobile apps for podcasts.

Liberated Syndication also offers advertisement insertion on certain of the producers’ content. Pertaining to Podcast Hosting Services, hosting is optimized for audio and video podcast distribution. The network is fast and reliable, and unmetered bandwidth and flexible storage space increases over time.

The Liberated Syndication publishing platform integrates content delivery to social media and blog platforms through OnPublish, the Company’s Facebook App and HTML5 player. OnPublish incorporates publishing to Facebook, Twitter, WordPress and Blogger right from Liberated Syndication (Libsyn).

Concerning MyLibsyn – Premium Content, it is a complete subscription management service. The MyLibsyn offering includes a custom premium page and mobile apps available across four markets. One’s subscribers sign up and create one username and password. They can access their subscription across all available apps and one’s branded premium page.

Liberated Syndication also has its LibsynPRO – Enterprise Solutions. This is for professional media producers and corporate customers. LibsynPRO features podcast network tools. It is a turn-key podcast network solution and it allows for as many different shows and episodes as required. In addition, effective reports convey sophisticated data on network, show, episode, device, and geographic performance.

Concerning Mobile Apps for Podcast, the Libsyn custom smartphone app for podcasters involves audiences beyond one’s regular audio or video episodes. Four different kinds of content are accepted by the app (audio, video, PDF and text). All in one place, a user can offer their audience extras, blog posts, transcripts, and more.

Earlier this month, Liberated Syndication announced that it closed its acquisition of Internet hosting company Pair Networks, Inc. on December 27, 2017. The Company paid $13.5 million in cash and issued 1,579,613 shares of restricted common stock valued at $2.5 million to acquire 100 percent of Pair Networks.

The combined businesses represented roughly $23 million in annual revenue and about $7 million in EBITDA (Earnings Before, Interest, Taxes, Depreciation, and Amortization) for 2017. As of December 31, 2017, the combined companies had roughly 82,000 monthly subscribers for hosting services. Management’s plan is to host a shareholder conference call during Q1 2018 to outline its plans for the combined companies in more detail.

Liberated Syndication, Inc. (LSYN), closed Monday's trading session at $1.60, up 0.63%, on 6,225 volume with 9 trades. The average volume for the last 60 days is 22,820 and the stock's 52-week low/high is $0.75/$1.90.

ProtoKinetix, Inc. (PKTX)

SmallCapVoice, OTCReporter, Stock Rich, PennyStockAce, Stockpalooza, SuperBirdStocks, WallStAlerts, Willy Wizard, Pick Alerts, Penny stock Profitz, AllPennyStocks, Penny Invest, CoolPennyStocks, TopPennyStockMovers, 777 Stocks, Breaking Bulls, InsideBulls, Stock Market News Alert, HotOTC, StockEgg, and Round Up the Bulls reported previously on ProtoKinetix, Inc. (PKTX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

ProtoKinetix, Inc. is a molecular biotechnology company headquartered in Marietta, Ohio. The Company has developed and patented a family of hyper stable, potent glycopeptides (Anti-Aging GlycoPeptide - AAGP™) that enhance engraftment and protection of transplanted cells used in regenerative medicine.

Due to the anti-inflammatory effect of AAGP™ molecules, ProtoKinetix is currently targeting the direct treatment of diseases that have a significant inflammatory component. The Company’s molecule, AAGP™, is an antifreeze glycopeptide. It imitates a naturally occurring glycoprotein found in Arctic fish.

ProtoKinetix’s AAGP™ molecule is helping to substantially improve the efficacy of Cell Transplant Treatments for diabetes. The Company has broad patent protection for its portfolio of anti-aging glycopeptides.

Its anti-aging glycopeptide, trademarked AAGP™, is a small (580.96 Daltons), stable, synthetic replica of the larger (>2,600 Daltons), less stable AFGP, which has been found to have protective properties in nature.

The small size of AAGP™ allows it to penetrate cells. It allows it to pass through cell and capillary junctions in vivo. Furthermore, its bioactivity at a range of pHs (5.3-10.3) and temperatures (-196°C to 22°C) and efficiency at concentrations (1mg/ml) is well under its toxic dose (50mg/ml). This makes it a candidate to enter the next stages of translational research.

ProtoKinetix and Proactive Immune Sciences entered into a joint research collaboration. The aim of the research is to test the effect of the patented anti-aging glycopeptide AAGP™ on the immune cell cryopreservation protocols used by Proactive Immune Sciences. Proactive Immune Sciences stores (banks) immune cells, while people are healthy. This is for them to use later in life should they contract cancer or have other immune system related diseases.

ProtoKinetix earlier provided a scientific update on immune cell banking and functions relevant to immunotherapy using AAGP™ in collaboration with Proactive Immune Sciences. In 2017, Proactive began a research program, which used an anti-aging glycopeptide (AAGP™) produced by ProtoKinetix that, among other uses, has shown the potential to benefit a variety of cells during cryopreservation.

In January 2018, ProtoKinetix announced that it entered into a research agreement with The University of British Columbia (UBC), under the direction of principal investigator Dr. Kelly McNagny, Professor, Faculty of Medicine, Department of Medical Genetics. The research agreement is to test and establish the effect of AAGP™ on monoclonal antibody production and bone marrow recovery.

The University of British Columbia’s Antibody Lab will test whether AAGP™ enhances the production of monoclonal antibodies from cell lines. Additionally, UBC will test whether AAGP™ enhances the survival/efficacy of engraftment of hematopoietic stem cells.

ProtoKinetix, Inc. (PKTX), closed Monday's trading session at $0.0489, even for the day, on 2,600 volume with 2 trades. The average volume for the last 60 days is 45,533 and the stock's 52-week low/high is $0.03/$0.0855.

iAnthus Capital Holdings, Inc. (ITHUF)

Stockhouse, MarketWatch, InvestorsHub, Daily Marijuana Observer, and OTC Markets reported on iAnthus Capital Holdings, Inc. (ITHUF), and we are reporting on the Company as well, here at the QualityStocks Daily Newsletter.

iAnthus Capital Holdings, Inc. is a provider of capital investment and management services to licensed cannabis cultivators, processors, and dispensaries throughout the United States. The Company, via its 100 percent owned subsidiary, iAnthus Capital Management, LLC, delivers a complete solution for financing and managing these enterprises. iAnthus supports a varied portfolio of cannabis industry investments. iAnthus Capital Holdings has its head office in New York, New York. The Company also has a Toronto, Ontario office.

Entrepreneurs with decades of experience in investment banking, corporate finance, law, and healthcare services founded iAnthus Capital Holdings. iAnthus remains hands-on with its investments. It works with its partners to optimize opportunities, overcome hurdles, and maximize value.

iAnthus owns, operates, and partners with licensed cannabis operations across the United States. It provides a unique combination of capital and practical operating and management expertise.

The Company creates agreements that establish valuable partnerships. It has developed strategic partnerships with best-in-class industry-sector leaders in dispensary operations, commercial-scale cannabis cultivation, regulatory law, and the science of cannabis product formulation and testing.

iAnthus applies meticulous analysis to ascertain the very best business prospects in each market throughout the U.S. The Company’s current portfolio includes Grassroots Vermont; Mayflower Medicinals, Inc.; Organix, Breckenridge Colorado; and R. Greenleaf Organics.

Earlier this month,  iAnthus Capital Holdings announced that Mayflower Medicinals received its final certificate of registration (FCR) and certificate of occupancy (CO) from Massachusetts regulators and local officials on December 28, 2017 to start cannabis cultivation and production operations at its facility in Holliston, Massachusetts.

Mayflower Medicinals is a non-profit Massachusetts corporation. It has received two provisional licenses to operate Registered Marijuana Dispensaries (RMDs) in Massachusetts, with a third RMD application pending before the Massachusetts Department of Public Health (DPH).

Furthermore, iAnthus announced the completion of its acquisition of 80 percent of Pilgrim Rock Management, LLC. Pilgrim Rock is an affiliated management and services company. It will provide intellectual property (IP) licensing, professional and management services, real estate and equipment leasing, and certain other services to Mayflower Medicinals, pursuant to a services agreement between Pilgrim Rock and Mayflower effective as of January 1, 2018.

Last week, iAnthus Capital Holdings announced it acquired by way of merger and acquisition transactions substantially all of the assets of GrowHealthy Holdings, LLC and certain related subsidiaries. The Acquisition completes iAnthus Capital’s full-scale entry into the fast expanding Florida medical cannabis market. iAnthus earlier acquired roughly 6 percent of GrowHealthy in a preferred share purchase in October 2017.

iAnthus Capital Holdings, Inc. (ITHUF), closed Monday's trading session at $3.53, up 3.82%, on 153,906 volume with 415 trades. The average volume for the last 60 days is 138,623 and the stock's 52-week low/high is $1.325/$5.0802.

Rhino Resource Partners LP (RHNO)

Marketbeat, TopPennyStockMovers, Wall Street Mover, and PCG Advisory reported previously on Rhino Resource Partners LP (RHNO), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.

Rhino Resource Partners LP is a diversified energy limited partnership based in Lexington, Kentucky. It concentrates on coal and energy related assets and activities. This includes energy infrastructure investments. Rhino is a diversified energy MLP (Master Limited Partnership). It produces coal in manifold basins in the United States Rhino Resource Partners lists on the OTC Markets’ OTCQB.

The Company produces metallurgical and steam coal in a variety of basins across the U.S. Moreover, Rhino leases coal via its Elk Horn subsidiary. The Company’s strategy is to acquire coal reserves and properties with relatively long lives and that could undergo development with low risk at a reasonable cost.

Rhino Resource Partners produces steam coal used to generate electricity and metallurgical coal used in the steel-making process. Additionally, Rhino manages and leases coal properties and collects royalties from such management and leasing activities. The Company also has oil and gas investments in the Cana Woodford region, which provides added cash flows to its business.

Through acquisitions and other coal lease transactions, Rhino Resource Partners has significantly increased its proven and probable coal reserves and non-reserve coal deposits. In addition, the Company has successfully grown its coal production by way of internal development projects.

In December of 2016, Rhino Resource Partners announced that it entered into an option agreement with Royal Energy Resources, Inc. (ROYE), Rhino Resource Partners Holdings, LLC (Rhino Holdings), an entity wholly-owned by certain investment partnerships managed by Yorktown Partners LLC, and Rhino GP LLC, the general partner of Rhino. Rhino received an option (Call Option) from Rhino Holdings to acquire substantially all of the outstanding common stock of Armstrong Energy, Inc. currently owned by investment partnerships managed by Yorktown.

The Option Agreement specifies that Rhino can exercise the Call Option no earlier than January 1, 2018, and no later than December 31, 2019. In exchange for Rhino Holdings granting Rhino the Call Option to purchase Armstrong Energy, the Partnership issued 5.0 million new common units (Call Option Premium Units) to Rhino Holdings upon the execution of the Option Agreement.

This past November, Rhino Resource Partners announced that it closed an agreement with a third party to transfer 100 percent of the memberships interests and related assets and liabilities in the Partnership’s Sands Hill Mining LLC entity to the third party in exchange for a future override royalty for any mineral sold, excluding coal, from Sands Hill after the closing date.

The third party assumed the surface coal mining operations and the limestone operations at Sands Hill.  The Partnership maintained ownership of an Ohio River barge loading facility, which was previously owned and operated by the Sands Hill entity. The Partnership’s belief is that this asset can provide considerable value to Rhino Resource Partners via the sale or potential lease of the facility.

Rhino Resource Partners LP (RHNO), closed Monday's trading session at $2.01, up 1.52%, on 200 volume with 1 trade. The average volume for the last 60 days is 1,384 and the stock's 52-week low/high is $1.10/$4.29.

Cannabis Sativa, Inc. (CBDS)

Flagler Financial Group, TheMicrocapNews, TopStockAnalysts, Top Pros’ Top Picks, Insider Financial, Darwin Investing Network, Wall Street Mover, Stock Beast, Promotion Stock Secrets, Jason Bond, Marketbeat.com, TopPennyStockMovers, Stockgoodies, Cannabis Financial Network News, Greenbackers, smartOTC, and Real Pennies reported earlier on Cannabis Sativa, Inc. (CBDS), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Cannabis Sativa, Inc. engages in branding and licensing through its 'hi' intellectual properties. The Company engages, via its subsidiaries, Wild Earth Naturals and "hi" Brands International, Inc., in the research, development, and licensing of specialized natural products. These include formulas, edibles, topicals, recipes, as well as delivery systems. Cannabis Sativa has been active in pursuing Intellectual Property (IP). It has successfully acquired an increasing portfolio of IP. Cannabis Sativa is based in Mesquite, Nevada, and the Company lists on the OTCQB.

Cannabis Sativa brands, licenses, innovates, and markets premier plant-derived topical creams, transdermals, balms, sublinguals, lubricants, and edibles for medical and recreational marijuana consumers, and legal nutraceuticals and branded merchandise for consumers in general.

Cannabis Sativa looks for strategic partners for acquisition of operating companies, intellectual property (IP), and other assets that fit within its corporate vision. Also, the Company holds a U.S. patent on the Ecuadorian Sativa strain of Cannabis, and owns patent pending and trade secret formulas and processes.

The Company’s wholly-owned subsidiary, Hi Brands International, entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products. Their CBD capsules are marketed under the name, "hi CBD."

Cannabis Sativa acquired a majority ownership interest in iBudtender, Inc., a Colorado corporation. In addition, it entered into an agreement to acquire a 49 percent ownership interest in a nine-acre property in Los Angeles County, California.

The ownership group’s intention is to lease the property to an industrial hemp farm operator. The operator will conduct farming activities under the Industrial Hemp provisions of California's Adult Use Marijuana Act (Prop 64).

Cannabis Sativa has its Wild Earth Naturals offerings. It offers the Wild Earth Naturals line of CBD Water and cosmetic products designed to use organic and natural ingredients. These include CBD and hemp seed oil.

The Company also entered into a license agreement for the manufacture, marketing, and sale of its White Rabbit products in California. It closed its acquisition of the White Rabbit brand of cannabis sprays and cannabis mints. The acquisition includes the exclusive and proprietary product formulations, product mixes, manufacturing methods, and also branding.

Cannabis Sativa acquired a controlling interest in PrestoCorp (a.k.a. PrestoDoctor). This is an online telemedicine platform. It provides access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation utilizing secure video conferencing technology. PrestoDoctor® is the top online medical marijuana recommendation service.

Cannabis Sativa’s PrestoDoctor® expanded to Pennsylvania on April 20, 2018. Greater than 3,800 people signed up in the medical marijuana patient registry's first week. The program will give those with one of 17 specific diagnoses access to cannabis starting in 2019.

PrestoDoctor® is addressing the lack of physicians with its #1 ranked telemedicine platform. This platform streamlines much of the process. Prospective patients fill out a short online application, choose an appointment time, and talk to a physician.

Cannabis Sativa, Inc. (CBDS), closed Monday's trading session at $4.22, up 1.93%, on 44,654 volume with 174 trades. The average volume for the last 60 days is 71,552 and the stock's 52-week low/high is $2.61/$9.74.

The QualityStocks Company Corner

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42)

The QualityStocks Daily Newsletter would like to spotlight FANDOM SPORTS Media Corp. (FDMSF).

Fan-focused entertainment company FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRANKFURT: TQ42) this morning released a corporate update detailing its recently accomplished internal milestones and current growth initiatives. To view the full press release, visit: http://nnw.fm/c3seE.

FANDOM SPORTS Media Corp. (CSE: FDM) (OTC: FDMSF) (FRA: TQ42) taps into the primal, unfiltered passion of sports fans from around the world by providing an uncensored social media platform delivered through the FANDOM SPORTS mobile app. As an aggregator, curator and instigator of both company-created and user-generated content, the FANDOM SPORTS app is designed to entertain sports enthusiasts with real-time, interactive content on a mobile only app that offers bragging rights and real-life rewards. True sports addicts will appreciate an app that allows fans to pick a fight or create their own FanFights and rule over others as they trash talk their way to victory. The FANDOM SPORTS proprietary data centric “argument engine” measures and scores opinionated dialogue, as well as establishes consensus, giving fans and users the ability to dive deeper into one-of-a-kind cultural moments, cheer on favorite sports teams and slam dunk some sweet rewards.

Building on the company’s tag line – “Pick a Fight” – the FANDOM SPORTS app provides an always fresh, authentic rush of deeper-than-surface interactive content that resonates with the targeted age demographic of 18-34. Intense sports fans aren’t afraid of stepping up to the plate to engage other users by unleashing their opinions within the app’s structured debate resolution tool coined “FanFights.” Sports-loving fans can explore, gloat, vote, invite friends, create provocative FanFight topics and play to win while inside the FANDOM SPORTS app, which is currently available in the Apple App store and coming to the Google Play store imminently. The company’s self-learning algorithm predicts and collects user preferences while building relevant personalized FanFight channels, bringing the concept of competitive, in-your-face conversation to a whole new level of sports entertainment.

The FANDOM SPORTS app is free to play (F2P) with in-app purchase and subscription capabilities. The gaming aspect of the ecosystem is built on behavioral economics and delivers multiple revenue streams by maximizing average revenue per daily active user (ARPDAU) and user-generated content (UGC), with select placement of high-impact video and moment-based marketing as part of the brand-sponsored FanFights and in-app offers. The global platform enables applications (either FANDOM SPORTS created or 3rd party apps) to be operated in partnership with leading sports themed brands, leagues, and service providing companies within three verticals – live action, eSports, & fantasy – from around the world by supplying “interactive sports entertainment” to fans. The FANDOM SPORTS platform creates a bullet-proof snapshot of the app’s fan base through a Blockchain supported “PlayerCard” in tandem with the “Engagement Score”, which doubles as an invaluable acquisition and retention tool for its business operators. FANDOM SPORTS hosted transactions are placed on the distributed ledger, making them immutable and public to verified users interacting within the business ecosystem. Tracking this digital footprint provides extremely valuable metadata generated by users’ very dynamic behavior and sports passion.

FANDOM SPORTS’ Brand and Sponsorship partners are harnessing the affluent sports fans age 18-34 with integrated marketing content and service experience. The moments-based marketing integration will translate through FanCoin redemption, in exchange for items provided by programs established by FANDOM SPORTS and its clients. These programs are a key part of the business model and covers, as an example, the following partners; Sports Leagues, TelCo’s service offerings, and Content owners (i.e. FANDOM SPORTS provides new paying customers to the owners of pay-per-view platforms).

“Pick A Fight. Talk Trash. Get Rewarded.”

FANDOM SPORTS Media is an entertainment company that aggregates, curates and produces unique fan-focused content.

The FANDOM SPORTS App is the Company’s core product, which is the ultimate destination for unfiltered raw sports talk. The app allows passionate sports fans to unleash their primal sports passions, pick fights and earn rewards.

So download the app and bring your crew. Talking trash is better with friends. The more you invite, the more FanCoins you earn.

You may also visit the Company’s website at www.fandomsportsmedia.com or contact them directly at info@fandomsportsmedia.com.

DISCLAIMER:

The CSE has not reviewed and does not accept responsibility for the adequacy and accuracy of this information. This news release may contain forward-looking statements. These forward-looking statements do not guarantee future events or performance and should not be relied upon. Actual outcomes may differ materially due to any number of factors and uncertainties, many of which are beyond the Company’s control. Some of these risks and uncertainties may be described in the Company’s corporate filings (posted at www.sedar.com).

The Company has no intention or obligation to update or revise any forward-looking statements due to new information or events

FANDOM SPORTS Media Corp. (FDMSF), closed the day's trading session at $0.0829, up 16.76%, on 500 volume with 1 trade. The average volume for the last 60 days is 15,509 and the stock's 52-week low/high is $0.0629/$0.3911.

Recent News

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

Premier financial information company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced its entry into a letter of intent to acquire the assets of XBTeller.com, a leading Colorado cryptocurrency ATM and over the counter operation. To view the full press release, visit: http://cnw.fm/n5E8O. Also today, NetworkNewsWire released a report on the company detailing how CIIX is increasingly focused on bolstering its leadership role for its global Chinese-speaking audience as producer and educator about global news regarding bitcoin, cryptocurrency, and blockchain technology through its website, NewCoins168.com. It has also launched a paid VIP Service on the site and expanded it into China.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.53, up 3.92%, on 164,706 volume with 80 trades. The average volume for the last 60 days is 53,787 and the stock's 52-week low/high is $0.40/$1.58.

Recent News

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) this morning announced that it has found a 58+ square kilometer lithium brine target area at its Coipasa project in Chile through transient electromagnetic surveys. To view the full press release, visit: http://nnw.fm/0P46v.

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.6772, even for the day. The average volume for the last 60 days is 1,983 and the stock's 52-week low/high is $0.6599/$0.9021.

Recent News

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Rising medical cannabis products and services provider Sunniva Inc. (CSE: SNN) (OTCQX: SNNVF) issued a report on April 30 detailing its financial results from fiscal year 2017 (http://cnw.fm/t48SZ).

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $6.77, off by 0.44%, on 51,911 volume with 123 trades. The average volume for the last 60 days is 37,562 and the stock's 52-week low/high is $6.035/$16.00.

Recent News

Zenergy Brands, Inc. (ZNGY)

The QualityStocks Daily Newsletter would like to spotlight Zenergy Brands, Inc. (ZNGY).

Zenergy Brands (OTCQB: ZNGY) recently unveiled a new associate program which was created to support sales of the company’s full suite of products and services. To view the full press article, visit: http://nnw.fm/4iocR. Also today, NetworkNewsWire released a report on the company detailing how ZNGY is a pioneering energy and technology company that operates within the smart energy, conservation and utilities industries, delivering retail energy, energy conservation, smart controls and efficiency-based products and services that are tailored to residential, commercial, industrial and municipal end-use customers.

Zenergy Brands, Inc. (ZNGY) is the nation’s leading next-generation energy and technology company operating in the emerging smart energy, conservation, and utility industries. Headquartered in Texas, Zenergy provides an entire suite of conservation-based products and services that enable clients to achieve sustainability goals, reduce carbon emissions and improve their bottom line. The company’s cutting-edge Zero Cost Program™ reduces utility expenses by 20 percent to 60 percent by offering energy conservation, smart controls, and efficiency-based products and services to residential, commercial, industrial and municipal end-use customers.

The Zero Cost Program™ is a financing mechanism that allows customers to reduce water, natural gas and electricity expenses by implementing proven conservation technologies at no out-of-pocket cost. The Zero Cost Program™ enriches businesses by immediately reducing energy consumption through the use of smart controls, building automation, LED lighting solutions, refrigeration optimization, efficient water systems, EC motor controls, demand-side management and load factor correction.

A unique Managed Energy Services Agreement (“MESA”) allows a portion of these utility savings to be retained by Zenergy’s partner financing the upgraded, retrofit equipment and installation costs until a specified repayment period ends. After that, clients reap all the financial rewards of the technologies implemented, which Zenergy estimates should range between 25 percent and 45 percent of total utility costs.

Residential customers seeking cost-effective energy savings can also choose from a suite of “Smart Home” products including home automation, security monitoring, and energy conservation services that can be controlled 24/7 from the comfort and convenience of their smartphones or internet-connected smart devices. Zenergy’s residential program offers partnership opportunities for homebuilders and residential, multi-family real estate developers to provide smart home technologies to high-end customers.

Zenergy Brands’ acquisition of Enertrade Electric LLC, a fully operating, licensed Texas-based Retail Electric Provider (REP), further increases the company’s value proposition. Zenergy CEO Alex Rodriguez said this new subsidiary adds an essential complementary service to the company’s suite of smart energy products and services.

“Since our founding, our vision has been to converge smart controls (home and building automation) with energy conservation and retail energy to deliver the comprehensive smart energy service to customers,” Rodriguez said.

On a global scale, residential and commercial buildings account for nearly 45 percent of the world’s total energy consumption. Improving the energy efficiency of these homes and buildings is often a more affordable way to reduce harmful gas emissions while minimizing the need for new energy production. According to Navigant Research, global revenue for energy-efficient commercial building retrofits alone is expected to grow from $71.4 billion in 2016 to $100.8 billion in 2025. At the same time, the energy-efficient devices market is expected to reach a market size of $908 billion by 2022. Increasing demands for reduction in energy consumption and greenhouse gas emissions along with concerns over climate change are contributing factors driving the market’s overall growth.

Zenergy Brands, Inc. (ZNGY), closed the day's trading session at $0.0077, off by 1.28%, on 1,778,400 volume with 41 trades. The average volume for the last 60 days is 3,051,185 and the stock's 52-week low/high is $0.0027/$0.045.

Recent News

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF).

Cobalt exploration and development company First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF), together with US Cobalt Inc. (TSX-V: USCO) (OTCQB: USCFF), this morning announced that two independent proxy advisory firms, Institutional Shareholder Services and Glass, Lewis & Co., have recommend that US Cobalt shareholders vote "FOR" the previously announced acquisition by First Cobalt. To view the full press release, visit: http://nnw.fm/1TebU.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.

First Cobalt Corp. (FTSSF), closed the day's trading session at $0.5854, off by 2.43%, on 140,507 volume with 74 trades. The average volume for the last 60 days is 144,473 and the stock's 52-week low/high is $0.3148/$1.3041.

Recent News

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTC: MCOA), through its hempSMART™ subsidiary, is dedicated to the scientific development of hemp-derived CBD-based nutritional products. To view the full article, visit: http://cnw.fm/bDG3u.

Marijuana Company of America Inc. (MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.028438, off by 1.09%, on 4,037,319 volume with 260 trades. The average volume for the last 60 days is 5,422,277 and the stock's 52-week low/high is $0.0181/$0.0728.

Recent News

The Green Organic Dutchman (TSX: TGOD)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (the “Company” or “TGOD”)  is pleased to announce the addition of several key executives including CFO, General Counsel, VP of Sales, VP of Marketing, VP of Operations, and Regional Sales Manager for Ontario and Western Canada.

The Green Organic Dutchman (TSX: TGOD), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $3.82, off by 3.29%, 1,398,374 volume. The stock's 52-week low/high is $3.74/$4.17.

Recent News

Consorteum Holdings, Inc. (CSRH)

The QualityStocks Daily Newsletter would like to spotlight Consorteum Holdings, Inc. (CSRH).

Through a joint business agreement with DevLex Ltd., Consorteum Holdings, Inc. (OTC: CSRH) announced on April 2, 2018, that it aims to release its first predictive data analytics mobile offering, dedicated to the game of cricket, during the second quarter of 2018 (http://nnw.fm/S0onj).

Consorteum Holdings, Inc. (CSRH) is a software development and mobile solutions company focused on the delivery of digital offerings to mobile devices. The company provides mobile offerings, delivery of mobile content, mobile payments solutions and products through a mix of direct offerings, partnerships, license agreements and joint venture arrangements. A multi-year transition from a transaction management company focused on transaction processing solutions and products for the payment processing and financial transaction markets to multiple business verticals deepens the company’s commitment to deliver innovating solutions to end users who are using smart handset devices in radical new ways.

Consorteum Holdings, utilizing its Universal Mobile Interface™ (“UMI”) solution, offers opportunities in numerous markets with its capacity to support fully regulated, regionally compliant financial and social transactions via web and mobile. The company’s UMI technology has the capacity to provide solutions in FinTech, data analytics, secure payment processing, compliance lead transaction management and various digital social event sectors. The UMI platform allows cross operating system development to support all mobile devices while addressing the complex and highly regulated needs of the mobile FinTech industry.

Led by the development team at Consorteum’s wholly owned subsidiary 359 Mobile Inc., the Company has created an end-to-end FinTech solution utilizing the company’s UMI technology platform. Current mobile application and transaction solutions are plagued by poor experiences. Because UMI’s technology platform is designed to work across innovative payment, experience and product solutions, 359 Mobile believes there are both direct and partnership opportunities for the 359 Mobile UMI solution.

Consorteum’s primary sales and marketing strategy is focused on enabling and delivering solutions to the global mobile FinTech market with an emphasis initially on mobile gaming. The trend towards increased mobile gambling supports the need for a mobile platform such as the UMI to meet existing and new compliance regulations for the online gambling industry. The online gambling market is projected to double to nearly $1 trillion by 2021, according to a study by Juniper Research, with the majority of growth in this sector attributed to mobile devices. Consorteum’s management team believes there are fresh opportunities in this sector such as Mobile Marketing Services providing one-to-one marketing experiences for consumers; offering real-time services to Mobile Sports Book operators; and providing fixed odds betting solutions as well as social-based transactional solutions.

Consorteum’s management team includes Chairman and CEO Craig A. Fielding, a co-founder of the company with extensive experience in technology, programming and large system building; and Chief Operating Officer Patrick Shuster, who has over 25 years of business experience in sales, engineering, operations and marketing for the telecommunications industry. They are joined by John Osborne, SVP of Technology of ThreeFiftyNine Inc., an innovator in embedded systems hardware and software design; Patrick Doran, SVP of business development and marketing with over 30 years of diversified experience in major corporations as well as early stage companies; and Glenn Charlesworth, VP of Accounting, a seasoned executive with a solid track record in financial reporting, strategic planning, general management and operations, finance, start-up situations, and cash flow challenged operations.

Consorteum Holdings is committed to bridging the mobile divide by providing mobile connectivity, secure transactional processing and social connectivity solutions for both cloud and hosted based offerings in multiple business sectors.

Consorteum Holdings, Inc. (CSRH), closed the day's trading session at $0.0016, off by 17.95%, on 2,676,090 volume with 30 trades. The average volume for the last 60 days is 9,476,096 and the stock's 52-week low/high is $0.0005/$0.0085.

Recent News

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF).

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced that it has signed a non-disclosure agreement ("NDA") with an internationally known drug delivery device manufacturer. To view the full press release, visit: http://cnw.fm/B3b3F.

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.

The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.

PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.215, off by 25.50%, on 28,220 volume with 8 trades. The average volume for the last 60 days is 21,701 and the stock's 52-week low/high is $0.01/$0.80.

Recent News

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ).

Epazz, Inc. (EPAZ) is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company’s strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

“We are starting 2018 with ZenaPay on both major mobile apps’ platforms,” said Shaun Passley, PhD, CEO and founder of Epazz. “We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company.”

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz’s unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

“Blockchain-based technology is the future of the Internet,” Passley said. “Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come.

Epazz, Inc. (EPAZ), closed the day's trading session at $0.0648, up 2.05%, on 75,902 volume with 19 trades. The average volume for the last 60 days is 172,326 and the stock's 52-week low/high is $0.0045/$0.52.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

370 N. Hayden Rd.
Suite 123-591
Scottsdale, AZ 85251
480-374-1336

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .